CVE-2022-38802

MEDIUMCVSS 6.2/10EPSS 0.64%

Last modified

CVE-2022-38802 is a medium-severity vulnerability rated 6.2/10 on the CVSS scale. Zkteco BioTime < 8.5.3 Build:20200816.447 is vulnerable to Incorrect Access Control via resign, private message, manual log, time interval, attshift, and holiday. An authenticated administrator can read local files by exploiting XSS into a pdf generator when exporting data as a PDF. EPSS estimates a 0.64% chance of exploitation in the next 30 days.

Description

Zkteco BioTime < 8.5.3 Build:20200816.447 is vulnerable to Incorrect Access Control via resign, private message, manual log, time interval, attshift, and holiday. An authenticated administrator can read local files by exploiting XSS into a pdf generator when exporting data as a PDF

Metrics

CVSS 3.1
6.2/10

CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:H/I:N/A:N

EPSS Probability
0.64%

46.0th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
ZktecoBiotime< 8.5.4

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2022-38802?
Zkteco BioTime < 8.5.3 Build:20200816.447 is vulnerable to Incorrect Access Control via resign, private message, manual log, time interval, attshift, and holiday. An authenticated administrator can read local files by exploiting XSS into a pdf generator when exporting data as a PDF
How severe is CVE-2022-38802?
CVE-2022-38802 has a CVSS score of 6.2/10 (MEDIUM severity). The EPSS model estimates a 0.64% probability of exploitation in the next 30 days.
How do I fix CVE-2022-38802?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2022-38802?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST